Jonathan Elliott Dickinson - Net Worth and Insider Trading
Jonathan Elliott Dickinson Net Worth
The estimated net worth of Jonathan Elliott Dickinson is at least $2 Million dollars as of 2023-05-29. Jonathan Elliott Dickinson is the EVP, General Manager, Europe of Incyte Corp and owns about 30,214 shares of Incyte Corp (INCY) stock worth over $2 Million. Details can be seen in Jonathan Elliott Dickinson's Latest Holdings Summary section.
Transaction Summary of Jonathan Elliott Dickinson
Jonathan Elliott Dickinson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Elliott Dickinson owns 1 companies in total, including Incyte Corp (INCY) .
Click here to see the complete history of Jonathan Elliott Dickinson’s form 4 insider trades.
Insider Ownership Summary of Jonathan Elliott Dickinson
|Ticker||Comapny||Transaction Date||Type of Owner|
|INCY||Incyte Corp||2019-06-19||EVP & General Manager & Europe|
Jonathan Elliott Dickinson Latest Holdings Summary
Jonathan Elliott Dickinson currently owns a total of 1 stock. Jonathan Elliott Dickinson owns 30,214 shares of Incyte Corp (INCY) as of January 31, 2022, with a value of $2 Million.
Latest Holdings of Jonathan Elliott Dickinson
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
Holding Weightings of Jonathan Elliott Dickinson
Jonathan Elliott Dickinson Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Elliott Dickinson has made a total of 2 transactions in Incyte Corp (INCY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Incyte Corp is the sale of 7,375 shares on January 31, 2022, which brought Jonathan Elliott Dickinson around $547,151.
Insider Trading History of Jonathan Elliott Dickinson
Jonathan Elliott Dickinson Trading Performance
Jonathan Elliott Dickinson Ownership Network
Ownership Network List of Jonathan Elliott Dickinson
Ownership Network Relation of Jonathan Elliott Dickinson
Jonathan Elliott Dickinson Owned Company Details
What does Incyte Corp do?
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Who are the key executives at Incyte Corp?
Jonathan Elliott Dickinson is the EVP & General Manager & Europe of Incyte Corp. Other key executives at Incyte Corp include Principal Accounting Officer Thomas Tray , EVP & Head of Tech. Operations Michael James Morrissey , and EVP & Chief Financial Officer Christiana Stamoulis .
Incyte Corp (INCY) Insider Trades Summary
Over the past 18 months, Jonathan Elliott Dickinson made 1 insider transaction in Incyte Corp (INCY) with a net sale of 7,375. Other recent insider transactions involving Incyte Corp (INCY) include a net purchase of 2,510,403 shares made by Baker Bros. Advisors Lp , a net sale of 30,111 shares made by Vijay K Iyengar , and a net sale of 46,866 shares made by Barry P Flannelly .
In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 208,851 shares of Incyte Corp (INCY) were sold and 2,510,403 shares were bought by its insiders, resulting in a net purchase of 2,301,552 shares.
Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Incyte Corp Insider Transactions
Jonathan Elliott Dickinson Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Elliott Dickinson. You might contact Jonathan Elliott Dickinson via mailing address: Care Of Incyte Corporation, 1801 Augustine Cut Off, Wilmington De 19803.